Skip to content
Learning that drives better investment decisions

Indonesia, Getting Hotter by the Day

By Become a Better Investor | Jun 28, 2017

Return-on-equity is still the highest among its Asian neighbors, and the nation’s GDP is growing at a healthy 5% clip thanks to private consumption and investment.

Read More

Hong Kong: The Ugliest Girl at the Dance

By Become a Better Investor | Jun 27, 2017

Overall the GDP growth in Hong Kong is slow. Hong Kong is least attractive in Asia. Consensus estimates for 2017-2018 earnings growth sit below the Asian average.

Read More

Korea Still the Most Attractive in Asia

By Become a Better Investor | Jun 26, 2017

The consensus EPS growth estimate in Korea for 2017 is a massive 40%, an attractive data point to be sure. Some investors may, however, take a wait-and-see approach to the new political establishment.

Read More

A Bit of Portfolio Tailoring Here, and a Touch of Hedging There

By Become a Better Investor | Jun 23, 2017

In our Top 5 this week, we look at the driving factor behind investing success and failure, uncover unsung investing heroes, and ask if we should worry about ETFs. All this and more…

Read More

Economy Gearing Up in Malaysia for 2017

By Become a Better Investor | Jun 22, 2017

Malaysia’s GDP made a run for it in the first quarter of 2017, clocking in at 5.6%—a rate not seen since the first quarter of 2015. Overall, Malaysia is relatively unattractive in Asia, considering all our four elements: Fundamentals, Valuation, Momentum, and Risk.

Read More

Singapore: Still Cheap, but for a Reason

By Become a Better Investor | Jun 21, 2017

Overall, Singapore is experiencing slow GDP growth. The market trades cheap, but worst momentum in Asia due to poor earnings growth and price momentum.

Read More

Taiwan: Attractive Valuation but Poor Momentum

By Become a Better Investor | Jun 20, 2017

Overall, Taiwan is experiencing slow GDP growth. Earnings growth has been poor, but on the positive side Taiwan has the highest dividend yield in Asia.

Read More

You Say Valeant Pharmaceuticals Share Is Still Worth US$200? | Anchoring

By Alexander Wetterling | Jun 19, 2017

What would be the reason for someone to think that a Valeant Pharmaceuticals share is still worth US$200? There may be many reasons for sure, but one of them is bound to be that the investor first bought the share at US$200 and, therefore, has anchored themselves to that price as the share’s value.

Read More

How to Start Building Your Wealth in the Stock Market for CFA in Shenzhen

By Become a Better Investor | Jun 17, 2017

Pictures from How to Start Building Your Wealth in the Stock Market for CFA in Shenzhen, China on 17 June 2017.

Read More

FVMR Investing – Quantamental Investing Across the World for CFA in Guangzhou

By Become a Better Investor | Jun 16, 2017

Pictures from FVMR Investing – Quantamental Investing Across the World for CFA Indonesia in Guangzhou, China on 16 June 2017.

Read More